ClinConnect ClinConnect Logo
Search / Trial NCT06692374

Automated Cardiac Arrest Detection and Alerting in Daily Life

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Nov 14, 2024

Trial Information

Current as of November 14, 2025

Not yet recruiting

Keywords

Automated Cardiac Arrest Detection Wearable Photoplethysmography Sudden Cardiac Death

ClinConnect Summary

This clinical trial is studying a new system that uses special wristbands to automatically detect cardiac arrest, which is when the heart suddenly stops beating. The trial aims to see how well this detection system works in people who already have an implantable cardioverter defibrillator (ICD), a device that helps monitor and treat dangerous heart rhythms. By quickly identifying a cardiac arrest event, the system can alert emergency responders faster, potentially improving survival rates.

To be eligible for this study, participants must be at least 18 years old, have an ICD, and be able to wear the wristband comfortably. They also need to own a smartphone that works with the wristband. If chosen for the trial, participants will wear this wristband during their daily activities, allowing researchers to see how accurately the device can recognize a cardiac arrest. It's important to note that individuals with certain medical conditions or those who may not be able to use the wristband properly will not be included in the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with an implantable cardioverter defibrillator (ICD)
  • Age 18 years or older
  • Fitting the wristband
  • In possession of a smartphone that is compatible with the wristband
  • Exclusion Criteria:
  • Known hemodynamically relevant bilateral subclavian artery stenosis
  • Medical issues that interfere with wearing of the wristband (e.g. skin disorders)
  • Insufficient skills to operate with the device/app

About Radboud University Medical Center

Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.

Locations

Nijmegen, Gelderland, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported